Aqua Med Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.16 M
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
- Satisfied Charges ₹ 6.00 M
- Revenue Growth -27.56%
- Profit Growth -34.37%
- Ebitda 83.39%
- Net Worth 10.22%
- Total Assets 12.79%
About Aqua Med
Aqua Med Private Limited (AMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 March 2004 and has a history of 20 years and ten months. Its registered office is in Baleswar, Odisha, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.16 M.
The company currently has active open charges totaling ₹7.00 M. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Tusarkanti Panda, Manas Panda, and Basanti Rath serve as directors at the Company.
Company Details
- Location
Baleswar, Odisha, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51223OR2004PTC007549
- Company No.
007549
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Aqua Med?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tusarkanti Panda  | Managing Director | 29-Mar-2004 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manas Panda | Director | 10-Apr-2007 | Current |
| Basanti Rath | Director | 11-Jul-2016 | Current |
Financial Performance of Aqua Med.
Aqua Med Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.56% decrease. The company also saw a substantial fall in profitability, with a 34.37% decrease in profit. The company's net worth Soared by an impressive increase of 10.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aqua Med?
In 2023, Aqua Med had a promoter holding of 25.70% and a public holding of 74.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.70 Cr
₹0.60 Cr
Charges Breakdown by Lending Institutions
- Uco Bank : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2019 | Uco Bank | ₹7.00 M | Open |
| 08 Jul 2004 | Andhra Bank | ₹6.00 M | Satisfied |
How Many Employees Work at Aqua Med?
Unlock and access historical data on people associated with Aqua Med, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aqua Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aqua Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.